CS logo
small CS logo
Instituto de Coloproctologia ICO S.A.S.

Medellin, Colombia
Médico en Medellín

About Instituto de Coloproctologia ICO S.A.S.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Hoffmann-La Roche
2
Takeda
2
Janssen Research & Development, LLC
1
Janssen Scientific Affairs, LLC
1
Total Rows: 5

Clinical Trials at Instituto de Coloproctologia ICO S.A.S.


During the past decade, Instituto de Coloproctologia ICO S.A.S. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100111100111100Started TrialsCompleted Trails201520162017201800.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Psoriasis Longitudinal Assessment and Registry
2007-06-21
2030-12-31
Recruiting
16,000
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
2012-07-20
2016-05-27
Completed
593
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
2012-06-01
2015-06-01
Completed
547
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
2012-10-01
2020-08-06
Completed
944
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-11-14
2020-05-25
Completed
358
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771
Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
2017-03-28
2018-06-13
Completed
1,731

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto de Coloproctologia ICO S.A.S." #1 sponsor was "Pfizer" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Takeda" with 2 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Janssen Scientific Affairs, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 3Pfizer: 3Hoffmann-La Roche: 2Hoffmann-La Roche: 2Takeda: 2Takeda: 2Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Janssen Scientific Affairs, LLC: 1Janssen Scientific Affairs, LLC: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Instituto de Coloproctologia ICO S.A.S.


According to Clinical.Site data, the most researched conditions in "Instituto de Coloproctologia ICO S.A.S." are "Ulcerative Colitis" (5 trials), "Colitis, Ulcerative" (2 trials), "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials) and "Inflammatory Bowel Diseases" (1 trials). Many other conditions were trialed in "Instituto de Coloproctologia ICO S.A.S." in a lesser frequency.

Clinical Trials Intervention Types at Instituto de Coloproctologia ICO S.A.S.


Most popular intervention types in "Instituto de Coloproctologia ICO S.A.S." are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Adalimumab" (2 trials), "CP-690,550" (2 trials), "Etrolizumab" (2 trials) and "Adalimumab Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto de Coloproctologia ICO S.A.S.


The vast majority of trials in "Instituto de Coloproctologia ICO S.A.S." are 9 trials for "All" genders.

Clinical Trials Status at Instituto de Coloproctologia ICO S.A.S.


Currently, there are NaN active trials in "Instituto de Coloproctologia ICO S.A.S.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Instituto de Coloproctologia ICO S.A.S., undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Coloproctologia ICO S.A.S., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1